Redox, a leader in healthcare interoperability has unveiled its new and improved product portfolio that will enable everyone from healthcare product teams to EHRs, payers and providers to use a composable healthcare digital strategy to adapt in an uncertain economy.
Redox CEO Luke Bonney stated, “With our new product portfolio, we're able to deliver value with greater scale, speed, and flexibility to better empower our customers to build healthcare experiences they couldn't previously imagine."
Here’s what to expect from Redox’s reimagined portfolio.
Redox Nexus
This managed integration platform will allow health tech builders to delight their users, modernise their tech stack, and scale with confidence.
Redox Nexus Lite
Nexus Lite is a self-service offering that combines core workflows and streamlined implementation to create a consistent, efficient integration process.
Redox Access
Access enables product teams to connect with national clinical networks and automate clinical record exchange with thousands of healthcare organisations.
Redox Chroma EMPI
Chroma is an Enterprise Master Patient Index (EMPI) powered by Verato that provides a single source of truth for patient identity.
Redox Nova
This product will make it much more efficient for organisations to utilise cloud-based AI and ML tools, enabling an interoperable record of patient data.
Professional Services
Redox is introducing a range of services including technical advising, project coordination, development work and maintenance.
Click here to read the original news story.